Accreditation Statistics

As of August 1, 2022

Cellular Therapy Entities

  • Accredited: 250
  • Applicants: 25

Cord Blood Banks

  • Accredited: 56
  • Applicants: 7

Congratulations to the following program for achieving initial FACT accreditation: King Abdulaziz Medical City - Riyadh, Saudi Arabia (adult and pediatric allogeneic and autologous hematopoietic progenitor cellular therapy; marrow and peripheral blood cellular therapy product collection; cellular therapy product processing with minimal manipulation). A complete list of accredited organizations can be found at www.factwebsite.org.

Just the FACTs 2022 Volume 3

Posted in :: 2022 Volume 3 :: Wednesday, August 17th, 2022

Letter from the President

In this month’s newsletter, there are updates regarding Standards from a variety of organizations, including ICCBBA, the United States Food and Drug Administration (FDA), and, of course, FACT. We work diligently to remain aware of and participate in public comment periods to advocate for the benefit of our accredited organizations and partners. I encourage all of you to also submit requested feedback whether as an individual, as part of your healthcare institution, or within your professional activities. The very nature of the FACT community is peer review and input, and it is important to apply this same principle to external organizations whose activities have an impact on our daily work caring for patients.

I also extend my congratulations to King Abdulaziz Medical City – Riyadh, Saudi Arabia for earning FACT accreditation! This is the first cellular therapy accreditation awarded by FACT in Saudi Arabia, and we commend the program for its dedication to achieving this confirmation of quality. FACT continues to offer its support globally to encourage accreditation and quality cellular therapy programs for patients everywhere.

Sincerely,

Catherine Bollard, MD
FACT President